Canaccord raised the firm’s price target on Okta (OKTA) to $100 from $94 and keeps a Hold rating on the shares. The firm said they reported ...

Canaccord analyst Kingsley Crane raised the firm’s price target on CrowdStrike (CRWD) to $420 from $370 and keeps a Buy rating on the shares.

Spine BioPharma, Inc., a development stage company committed to non-opiate, non-surgical therapies for Degenerative Disc ...

TTEC (NASDAQ:TTEC – Free Report) had its target price reduced by Canaccord Genuity Group from $4.50 to $3.50 in a research ...

Canaccord Genuity adjusted its stance on Evolution Mining Ltd. (EVN:AU) (OTC: CAHPF), downgrading the company's stock rating from Buy to Hold while maintaining a price target of AUD6.15. Currently ...

Fintel reports that on February 28, 2025, Canaccord Genuity downgraded their outlook for ICF International (NasdaqGS:ICFI) ...

Elastic (NYSE:ESTC – Free Report) had its price objective lifted by Canaccord Genuity Group from $130.00 to $135.00 in a ...

Analysts at Canaccord Genuity lowered their target price on discount retailer B&M from 545.0p to 495.0p on Tuesday following ...

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today ...

Analysts at Canaccord Genuity reiterated their 135.0p target price on airside solutions developer Aurrigo International on ...

Canaccord Genuity raised its price target on Snowflake (NYSE:SNOW) by $30 to $220, as company is set to report fourth-quarter earnings on Wednesday. Stabilizing growth and AI-driven expansion are key ...